13 completed, 7 terminated, 5 recruiting, 2 unknown. 29 Phase 2, 11 Phase 1, 4 Phase 3.
Follow Suspensions: new trials by email Literature Review of Suspensions trials Research Report on Suspensions
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| CEUS Evaluation of Hydrocephalus in Neonates and Infants Sulfur Hexafluoride Lipid Type A Microspheres 25 mg Injection Powder for Suspension [LUMASON] - Hydrocephalus in Infants, Hydrocephalus Acquired | Phase 2 | Recruiting | Children's Hospital of Philadelphia | 20 | 2026-11-30 | 2026-11-02 |
| Pharmacokinetic and Safety Study of Metronidazole Oral Suspension in Pediatric Patients With Anaerobic Bacterial Infection Likmez® (metronidazole) Oral Suspension - Bacterial Infections | Phase 2 | Not yet recruiting | Saptalis Pharmaceuticals LLC | 30 | 2025-08-01 | 2025-08-28 |
| RSV Vaccination in Immunocompromised Patients. Arexvy powder and suspension for injection - RSV Infection | Phase 2 | Recruiting | Medical University of Vienna | 200 | 2024-09-19 | 2024-11-27 |
| A Study of Deuremidevir Hydrobromide for Suspension in Chinese Infants Hospitalized With RSV Deuremidevir Hydrobromide for Suspension, Placebo - Respiratory Syncytial Virus Infection | Phase 2 | Completed | Vigonvita Life Sciences | 60 | 2024-01-31 | 2025-07-23 |
| Safety and Efficacy of MSC-EVs in the Prevention of BPD in Extremely Preterm Infants Endotracheopulmonary Instillation, Suspension - Bronchopulmonary Dysplasia | Phase 1 / Phase 2 | Recruiting | EXO Biologics S.A. | 265 | 2023-12-28 | 2024-09-19 |
| A Study to Learn About a Modified RNA Vaccine Against Shingles in Healthy Adults Candidate 1: PF-07915234: VZV modRNA Powder for Suspension for Injection, Candidate 1: PF-07915234: VZV modRNA Suspension for Injection, Candidate 2: PF-07921188: VZV modRNA Suspension for Injection - Shingles, Herpes Zoster Infection | Phase 1 / Phase 2 | Terminated | Pfizer | 484 | 2023-01-25 | 2026-05-04 |
| Biological Response to Platelet-rich Plasma and Corticosteroid Injections Triamcinolone Acetonide 40 mg/ml Inj, Susp, Platelet-rich plasma Inj - Knee Osteoarthritis | Phase 1 / Phase 2 | Terminated | University of Missouri-Columbia | 23 | 2022-12-28 | 2025-06-25 |
| Co-administration of Acetaminophen With Ibuprofen to Improve Duct-Related Outcomes in Extremely Premature Infants Acetaminophen Injection, Ibuprofen 20 mg/mL oral suspension or Ibuprofen lysine 10 mg/mL injection solution (Neoprofen), Sodium chloride 0.9% injection - Patent Ductus Arteriosus After Premature Birth | Phase 2 | Recruiting | Mount Sinai Hospital, Canada | 310 | 2022-12-12 | 2026-09-15 |
| Contrast Enhanced 3D Echocardiographic Quantification of Right Ventricular Volumes in Repaired CHD Sulfur Hexafluoride Lipid Type A Microspheres 25 MG Injection Powder for Suspension [LUMASON] - Tetralogy of Fallot, Pulmonary Insufficiency | Phase 1 / Phase 2 | Completed | Nemours Children's Clinic | 25 | 2022-08-23 | 2026-04-27 |
| A Phase 2a Study to Investigate REM0046127 in Mild to Moderate Alzheimer's Disease REM0046127 High Dose, REM0046127 Low Dose, Placebo - Alzheimer Disease | Phase 2 | Terminated | reMYND | 14 | 2022-06-07 | 2025-12-03 |
| A New Posaconazole Dosing Regimen for Paediatric Patients With Cystic Fibrosis and Aspergillus Infection Posaconazole 100 MG [Noxafil], Posaconazole 40 MG/ML - Cystic Fibrosis, Aspergillosis | Phase 2 / Phase 3 | Unknown | Bambino Gesù Hospital and Research Institute | 135 | 2021-04-22 | 2021-07-19 |
| Trial of NanoPac Intratumoral Injection in Lung Cancer NanoPac (sterile nanoparticulate paclitaxel) Powder for Suspension - Lung Cancer, Nonsmall Cell, Lung Cancer | Phase 2 | Completed | NanOlogy, LLC | 18 | 2021-04-14 | 2025-05-23 |
| The LUCINDA Trial: LeUprolide Plus Cholinesterase Inhibition to Reduce Neurological Decline in Alzheimer's Placebo, Eligard 22.5Mg Suspension for Injection - Alzheimer Disease, Mild Cognitive Impairment | Phase 2 | Completed | Weill Medical College of Cornell University | 86 | 2020-11-27 | 2026-09-21 |
| Trial of NanoPac Focal Therapy for Prostate Cancer NanoPac (sterile nanoparticulate paclitaxel) Powder for Suspension - Prostate Cancer, Prostate Adenocarcinoma | Phase 2 | Terminated | NanOlogy, LLC | 1 | 2020-10-20 | 2022-03-29 |
| Proof of Concept Trial of Vamorolone in Pediatric Ulcerative Colitis Vamorolone 4% suspension for oral dosing - Pediatric Ulcerative Colitis | Phase 1 / Phase 2 | Withdrawn | ReveraGen BioPharma, Inc. | 2020-09-01 | 2020-09-29 | |
| A Study of Repotrectinib in Pediatric and Young Adult Subjects Harboring ALK, ROS1, OR NTRK1-3 Alterations Oral repotrectinib (TPX-0005) - Locally Advanced Solid Tumors, Metastatic Solid Tumors | Phase 1 / Phase 2 | Recruiting | Turning Point Therapeutics, Inc. | 75 | 2020-03-12 | 2026-09-25 |
| Use of Topical NSAID to Reduce Pain in Oral Lichen Planus and Oral Lichenoid Lesions. Ibuprofen suspension 5mg/100ml, Placebos - Oral Lichen Planus, Oral Lichenoid Mucositis | Phase 2 / Phase 3 | Completed | University of Washington | 23 | 2018-04-29 | 2020-05-08 |
| Study of VX-121 in Healthy Subjects and in Subjects With Cystic Fibrosis Placebo (matched to VX-121 suspension), VX-121 (Suspension), TEZ/IVA - Cystic Fibrosis | Phase 1 / Phase 2 | Completed | Vertex Pharmaceuticals Incorporated | 115 | 2018-03-20 | 2022-07-14 |
| Evaluation of the Benefit of Antiviral Treatment With Valganciclovir on Congenital CMV Infection-related Deafness on Hearing and Balance Valganciclovir - Congenital Cytomegalovirus (CMV) | Phase 2 / Phase 3 | Terminated | Assistance Publique - Hôpitaux de Paris | 1 | 2017-07-11 | 2019-11-18 |
| Pharmacodynamic & Safety of Patiromer in Children & Adolescents (2-<18 Yrs) With Chronic Kidney Disease and Hyperkalemia Patiromer - Hyperkalemia | Phase 2 | Terminated | Vifor Pharma, Inc. | 23 | 2017-07-07 | 2022-10-19 |
Showing 20 of 29. Sign in to see all of them.
Hyperkalemia (4) · Renal Insufficiency, Chronic (3) · Alzheimer Disease (2) · Cystic Fibrosis (2) · HIV Infections (2) · Hypertension (2) · Respiratory Syncytial Virus Infections (2) · Aspergillosis (1) · Bacterial Infections (1) · Bronchopulmonary Dysplasia (1) · Carcinoma, Non-Small-Cell Lung (1) · Chickenpox (1) · Cognitive Dysfunction (1) · Cytomegalovirus Infections (1) · Diabetic Nephropathies (1)
Relypsa, Inc. (3) · NanOlogy, LLC (2) · National Institute of Allergy and Infectious Diseases (NIAID) (2) · Assistance Publique - Hôpitaux de Paris (1) · Bambino Gesù Hospital and Research Institute (1) · Bayer (1) · Children's Hospital of Philadelphia (1) · EXO Biologics S.A. (1) · Eli Lilly and Company (1) · Federal University of São Paulo (1) · L.V. Prasad Eye Institute (1) · Medical University of Vienna (1) · Mount Sinai Hospital, Canada (1) · Nemours Children's Clinic (1) · Pfizer (1)
United States (17) · Canada (5) · France (5) · United Kingdom (5) · Germany (4) · Italy (4) · Netherlands (4) · Spain (4) · Australia (3) · Brazil (3) · Georgia (3) · South Africa (3) · Austria (2) · Botswana (2) · Bulgaria (2)
Shelagh Verco, PhD (2) · Adilia Warris, Prof (1) · Amish Jain, MD PhD (1) · Andrew Wiznia, M.D. (1) · Andrew Wiznia, MD (1) · Beatrice De Vos, M.D., Ph.D. (1) · Craig S Atwood, PhD (1) · James E Galvin, MD (1) · Jort Vijverberg, MD (1) · Julian Platon, MD, PhD (1) · Koen De Witte, PhD (1)
PMID 32588430, PMID 15039276, PMID 15232472, PMID 18587624, PMID 23559821, PMID 24145879, PMID 25035839, PMID 28287489, PMID 29767459, PMID 30176673, PMID 30527329, PMID 31533906, PMID 31901394, PMID 32551947, PMID 34136782, PMID 34379314, PMID 34505846, PMID 34694878, PMID 34814185, PMID 34817414, PMID 34945097, PMID 35369022, PMID 35489377, PMID 40937833, PMID 41365527, PMID 42731017
2016 (2), 2015 (1), 2018 (1), 2019 (1), 2023 (1), R01AG057681 (1)